NERVOUS SYSTEM DYSFUNCTION

BRAIN DYSFUNCTION AND NEUROLOGICAL CONDITIONS

TRANSIENT LOSS OF CONSCIOUSNESS: SYNCOPE

  • Definition:

    • Transient, self-limited loss of consciousness (TLOC) resulting from acute global impairment of cerebral blood flow.

    • Characterized by rapid onset, brief duration, and spontaneous, complete recovery.

  • Epidemiology:

    • Accounts for approximately 3% of all emergency department visits and 1% of hospital admissions.

    • Lifetime incidence: up to 40% of the general population.

  • Age Distribution:

    • Peak incidence in youth (ages 10–30 years, median age ~15 years, primarily neurally mediated).

    • Sharp rise in syncope cases after age 70.

  • Common Causes:

    • Neurally mediated syncope, which is more common in younger patients and tends to have an excellent prognosis.

    • Cardiac causes (structural disease, arrhythmias) are more common in emergency departments and older adults.

  • Orthostatic Hypotension:

    • Increases with age due to reduced reflexes, cardiac compliance, and certain medications.

    • More frequent in institutionalized elderly.

PATHOPHYSIOLOGY OF SYNCOPE

  • Physiological Stress in Upright Posture:

    • Standing leads to pooling of 500–1000 mL of blood in the legs, buttocks, and splanchnic circulation.

    • Results in decreased venous return, reduced ventricular filling, decreased cardiac output, and lowered blood pressure.

  • Baroreceptors response:

    • Baroreceptors (in the carotid sinus and aortic arch) trigger sympathetic activity increase and vagal activity decrease to maintain blood pressure and cerebral perfusion.

  • Failure of Reflex Response:

    • Results in hypotension and cerebral hypoperfusion leading to syncope.

High-Risk Features Indicating Hospitalization or Intensive Evaluation of Syncope (TABLE 23-1)

  1. Chest pain suggesting coronary ischemia.

  2. Features of congestive heart failure.

  3. Moderate or severe valvular disease.

  4. Moderate or severe structural cardiac disease.

  5. Electrocardiographic features of ischemia.

  6. History of ventricular arrhythmias.

  7. Prolonged QT interval (>500 ms).

  8. Repetitive sinoatrial block or sinus pauses.

  9. Persistent sinus bradycardia.

  10. Bi- or trifascicular block or intraventricular conduction delay with QRS duration ≥120 ms.

  11. Atrial fibrillation.

  12. Nonsustained ventricular tachycardia.

  13. Family history of sudden death.

  14. Pre-excitation syndromes.

  15. Palpitations at the time of syncope.

  16. Syncope at rest or during exercise.

EEG PATTERNS IN CEREBRAL HYPOPERFUSION

  • Consciousness is lost if cerebral blood flow is interrupted for 6-8 seconds or drops to 25 mL/min per 100 g of brain tissue (normal is 50-60 mL/min).

  • Characteristics of EEG patterns:

    • Slow-flat-slow pattern with delta waves indicates severe cerebral hypoperfusion.

    • Slow pattern with fluctuating slow wave activity without seizure discharges, despite motor activity.

CLASSIFICATION OF SYNCOPE: UNDERLYING MECHANISMS

  1. Neurally Mediated (Reflex/Vasovagal) Syncope:

    • Triggered by emotions, pain, or orthostatic stress (most common in young patients).

  2. Orthostatic Hypotension:

    • Defined as a reduction in systolic BP of ≥20 mmHg or diastolic BP of ≥10 mmHg within 3 minutes of standing resulting from autonomic failure.

    • Common causes include neurogenic disorders such as Parkinson’s disease and certain medications (diuretics, antihypertensives).

  3. Cardiac Syncope:

    • Caused by arrhythmias (e.g., bradyarrhythmias like AV block or tachyarrhythmias like Ventricular Tachycardia). Represents high risk of sudden cardiac death.

THE BAROREFLEX IN SYNCOPE

  • Blood pressure drops stimulate baroreceptors which reduces input to the brainstem, leads to reduced vagal activity, and increases sympathetic activity.

  • If low pressure continues, vasopressin is released to conserve water, contributing to blood pressure rise.

CLINICAL FEATURES OF SYNCOPE

  • Symptoms include lightheadedness, dizziness, fatigue, nausea, diaphoresis, pallor, palpitations, yawning.

  • Patients may show myoclonic jerks and exhibit changes in pupil reaction, which are vital for diagnosis.

DIFFERENTIAL DIAGNOSIS OF SYNCOPE

  1. Seizures:

    • Frequently involves prolonged unconsciousness (>5 min) with specific auras and postictal confusion.

  2. Hypoglycemia:

    • Presents with hunger, tremors, anxiety; not TLOC due to hypoperfusion.

  3. Cataplexy:

    • Triggered by strong emotions; involves loss of muscle tone; consciousness remains intact.

  4. Psychogenic Pseudosyncope:

    • Frequent fainting without changes in hemodynamics.

DIAGNOSTIC EVALUATION FOR SYNCOPE

  • Initial assessment should include: detailed history, eyewitness accounts, physical examination including orthostatic vital signs.

  • ECG monitoring, tilt-table testing, carotid sinus massage, and Holter monitors may be indicated for further investigation.

MANAGEMENT AND TREATMENT OF NEURALLY MEDIATED SYNCOPE

  • Treatment focuses on education, salt/fluid expansion, and isometric counterpressure maneuvers.

  • Pacemakers may be indicated for bradyarrhythmias; medications may include midodrine or fludrocortisone to address underlying conditions.

EYE EXAMINATION IN NEUROLOGICAL DISORDERS

Key Vestibular Disorders such as Benign Paroxysmal Positional Vertigo (BPPV)

  • Characterized by brief (<1 min) episodes induced by gravity-related movements, typically arising from dislodged otoconia within semicircular canals.

Management Strategies:

  • Epley maneuver to reposition otoconia.

  • Short-term use of medications for active vertigo control, but prolonged usage should be avoided due to effects on central compensation and recovery.

FATIGUE IN CLINICAL MEDICINE

  • Fatigue represents a subjective experience of physical and mental weariness and may signal an underlying condition if persistent or disproportionate to trigger events.

COMMON CAUSES OF FATIGUE INCLUDE:

  • Psychiatric diseases (75-80%)

  • Neurological disorders affecting multiple sclerosis, Parkinson’s disease, and conditions post-stroke or TBI.

  • Endocrine/metabolic abnormalities.

  • Infections, with particular focus on post-COVID fatigue.

ASSESSMENT AND MANAGEMENT OF FATIGUE

  • Focus on detailed history, physical examination, and lab tests including basic screenings for CBC, electrolytes, and glucose.

  • Cognitive-Behavioral Therapy (CBT) can be beneficial in patients with ME/CFS and MS.

WEAKNESS AND PARALYSIS IN NEUROLOGICAL CONDITIONS

  • Definition of Weakness: Reduction in power exerted by muscles, distinct from increased fatigability or limitations due to pain.

  • Weakness can be categorized based on motor system localization, which influences further diagnostic strategy.

DIAGNOSTIC INVESTIGATION FOR WEAKNESS INCLUDE:

  • Brain/Spine CT and MRI for UMN/CNS patterns.

  • Electromyography (EMG) and nerve conduction studies for LMN/muscle-based weakness.

SENSORY ABNORMALITIES IN NEUROLOGICAL CONDITIONS

  • Positive symptoms: excessive activity characterized by abnormal sensations (tingling, burning).

  • Negative symptoms: indicative of sensory loss including numbness or diminished feeling, needing significant axonal loss before becoming clinically evident.

GAIT DISORDERS IN ELDERLY PATIENTS

  • Affecting approximately 15% of adults over 65, increasing with age.

  • Common gait disorders include antalgic gait due to pain, unilateral or bilateral weakness, presenting in multiple forms, such as cautious or stooped posture associated with specific conditions.

CLINICAL EXAMINATION: GAIT OBSERVATION

  • Important features to assess include cadence, stride, and turning ability, affected by balance control primitives.

CONFUSION AND DELIRIUM

  • Confusion: Mental state characterized by reduced comprehension, coherence, and reasoning capacity, often common in hospital visits.

  • Delirium: Acute confusion state reflecting serious underlying illness with hallmarks such as rapid onset attention deficits often requiring immediate medical attention.

RISK FACTORS AND EPIDEMIOLOGY OF DELIRIUM

  • Major risk factors identify elderly populations vulnerable to delirium (age >65, baseline cognitive impairment).

  • Prevalence is particularly high in ICU settings and nursing homes, requiring heightened surveillance.

COMA AND ALTERED STATES OF CONSCIOUSNESS

  • Coma: Characterized by an inability to be aroused; differential states (drowsiness/stupor) providing necessary clinical context for assessment.

  • Classifications such as vegetative states indicate varying prognostics, reflecting injury severity and recovery outcomes.

EVALUATING A PATIENT IN COMA

  • Assessment includes vital signs, medical history, and neurological examination to identify reversible etiologies or ensure appropriate intervention planning.

DEMENTIA: DEFINITION AND EVALUATION

  • Cognitive decline impacting daily function with significant implications on memory and executive function.

  • Evaluation necessitates thorough histories and cognitive assessments to assess for treatable causes.

TREATMENT OF DEMENTIA

  • Addresses both reversible factors as collaboration with multidisciplinary teams for management, education, and caregiver support.

APHASIAS: UNDERSTANDING LANGUAGE IMPAIRMENTS

  • Classified by types including Wernicke's, Broca’s, and conduction aphasia which highlight specific disruptions based on lesion locations.

  • Correct evaluation informs rehabilitative strategies and enhances patient outcomes in post-stroke recovery.

SLEEP DISORDERS: OVERVIEW

  • Discusses physiology and regulation of sleep, identifying disorders characterized by excessive sleepiness or insomnia and their impact on overall health.

  • Treatment stratifies approaches based on individual sleep-wake cycle disruptions, emphasizing lifestyle modifications, behavioral interventions, and pharmacological approaches where indicated.

CONCLUSION

  • Understanding these neurological conditions through detailed clinical evaluation enables better patient management strategies, highlighting the importance of an interdisciplinary approach to treatment and care.